Enhancement of tumour response to photodynamic therapy by adjuvant mycobacterium cell-wall treatment

Journal of Photochemistry and Photobiology B: Biology

Volumn 44, Issue 2, 1998, Pages 151-158

  Korbelik, Mladen ^a   Cecic, Ivana ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

BCG; Immunotherapy; Inflammatory cells; Mouse mammary sarcoma; Mycobacterium cell wall; Photodynamic therapy; Tumour immunity

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; PHOTOFRIN; PHOTOSENSITIZING AGENT; PHTHALOCYANINE ZINC;

ANIMAL TISSUE; BONE MARROW CELL; BREAST SARCOMA; CELL INFILTRATION; CELL WALL; CONFERENCE PAPER; CONTROLLED STUDY; IMMUNOMODULATION; INFLAMMATION; MOUSE; MYCOBACTERIUM; NEUTROPHIL; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TUMOR REGRESSION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BCG VACCINE; CYTOSKELETAL PROTEINS; DRUG COMBINATIONS; LIPID A; MICE; MICE, INBRED BALB C; PHOTOCHEMOTHERAPY; SARCOMA, EXPERIMENTAL; TUMOR CELLS, CULTURED;

ANIMALIA; MURINAE; MYCOBACTERIUM; MYCOBACTERIUM BOVIS BCG;

EID: 0032503868     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(98)00138-9     Document Type: Conference Paper

References (33)

1. [1] J.J. Schuitmaker, P. Baas, H.L.L.M. van Leengoed, F.W. van der Meulen, W.M. Star, N. van Zandwijk, Photodynamic therapy: a promising new modality for the treatment of cancer, J. Photochem. Photobiol. B: Biol. 34 (1996) 3-12.
2. [2] B.W. Henderson, T.J. Dougherty, How does photodynamic therapy work?, Photochem. Photobiol. 55 (1992) 145-157.
3. [3] M. Korbelik, Induction of tumor immunity by photodynamic therapy, J. Clin. Laser Med. Surg. 14 (1996) 329-334.
4. [4] T.J. Dougherty, C.J. Gomer, B.W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, Q. Peng, Review: photodynamic therapy, J. Natl. Cancer Inst., in press.
5. [5] W.J.A. de Vree, M.C. Essers, H.S. DeBrujin, W.M. Star, J.F. Koster, W. Sluiter, Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo, Cancer Res. 56 (1996) 2908-2911.
6. [6] M. Korbelik, V.R. Naraparaju, N. Yamamoto, Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer, Br. J. Cancer 75 (1997) 202-207.
7. [7] G. Krosl, M. Korbelik, Potentiation of photodynamic therapy by immunotherapy: the effect of schizophyllan (SPG), Cancer Lett. 84 (1994) 43-49.
8. [8] V.F. Dima, V. Vasiliu, D. Laky, M.D. Ionescu, S.V. Dima, Treatment of rat Walker-256 carcinosarcoma with photodynamic therapy and endotoxin irradiated with high energy electrons, Proc. SPIE 2078 (1994) 547-557.
9. [9] R.C. Myers, B.H.S. Lau, D.Y. Kunihira, R.R. Torrey, J.L. Wooley, J. Tosk, Modulation of hematoporphyrin derivative-sensitized phototherapy with Corynebacterium parvumin murine transitioned cell carcinoma. Urology 33 (1989) 230-235.
10. [10] Y.-H. Cho, R.C. Straight, J.A. Smith Jr., Effects of photodynamic therapy in combination with intravesical drugs in a murine bladder tumor model, J. Urol. 147 (1992) 743-746.
11. [11] N. Schultz, R. Oratz, D. Chen, A. Zeleniuch-Jacquotte, G. Abeles, J.C. Bystryn, Effect of DETOX as an adjuvant for melanoma vaccine, Vaccine 13 (1995) 503-508.
12. [12] J.D. Geiger, P.D. Wagner, M.J. Cameron, S. Shu, A.E. Chang, Generation of T-cells reactive to the poorly immunogenic B16-BL6 melanoma with efficacy in the treatment of spontaneous metastases, J. Immunother. 13 (1993) 153-165.
13. [13] D.L. Lamm, A.D. van der Meijden, A. Morales, Incidence and treatment of complications of Bacillus Calmette-Guérin intravesical therapy in superficial bladder cancer, J. Urol. 147 (1992) 596-600.
14. [14] M.A. Weinberg, R.G. Margolese, D.W. Weiss, Tumor immunoprophylaxis in guinea pigs treated with the methanol extraction residue (MER) of BCG, in: G. Lamoreux, R. Turcotte, V. Portelance (Eds.), BCG in Cancer Immunotherapy, Grune and Stratton, New York, 1976, pp. 39-50.
15. [15] A. Morales, J.C. Nickel, J. Downey, J. Clark, I. van der Linden, Immunotherapy of an experimental adenocarcinoma of the prostate, J. Urol. 153 (1995) 1706-1710.
16. [16] S.A. Vezina, D. Archambault, Modulatory effect of mycobacterium cell wall extract (Regressin) on lymphocyte blastogenic activity and macrophage cytokine gene transcription in swine, Clin. Diagn. Lab. Immunol. 4 (1997) 314-320.
17. [17] J.S. Berman, R.L. Blumenthal, H. Kornfeld, J.A. Cook, W.W. Cruikshank, M.W. Vermeulen, D. Chatterjee, J.T. Belisle, M.J. Fenton, Chemotactic activity of mycobacterial lipoarabinomannans for human blood T lymphocytes in vitro, J. Immunol. 156 (1996) 3828-3835.
18. [18] J.L. Adams, C.J. Czuprynski, Ex vivo induction of TNF-alpha and IL-6 mRNA in bovine whole blood by Mycobacterium paratuberculosis and mycobacterium cell wall components, Microb. Pathog. 19 (1995) 19-29.
19. [19] J.L. Chin, S.A. Kadhim, E. Batislam, S.J. Karlik, B.M. Garcia, J.C. Nickel, A. Morales, Mycobacterium cell wall: an alternative to intravesical Bacillus Calmette-Guérin (BCG) therapy in orthotopic murine bladder cancer, J. Urol. 156 (1996) 1189-1193.
20. [20] S.C. Rockwell, R.F. Kallman, L.F. Fajardo, Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative, J. Natl. Cancer Inst. 49 (1972) 735-749.
21. [21] M. Korbelik, G. Krosl, Photofrin accumulation in malignant and host cell populations of various tumours, Br. J. Cancer 73 (1996) 506-513.
22. [22] G. Krosl, M. Korbelik, G.J. Dougherty, Induction of immune cell infiltration into murine SCCVII tumour by Photofrin-based photodynamic therapy, Br. J. Cancer 71 (1995) 549-555.
23. [23] C. Milanesi, C. Zhou, R. Biolo, G. Jori, Zn(II)-phthalocyanine as a photodynamic agent for tumours. II. Studies on the mechanism of photosensitized tumour necrosis, Br. J. Cancer 61 (1990) 846-850.
24. [24] K. Schieweck, H.-G. Capraro, U. Isele, P. van Hoogevest, M. Ochsner, T. Maurer, E. Batt, CGP 55847, liposome-delivered zinc(II)-phthalocyanine as a phototherapeutic agent for tumors, Proc. SPIE 2078 (1994) 107-118.
25. [25] R. Whelpton, A.T. Michael-Titus, R.P. Jamdar, K. Abdillahi, M.F. Grahn, Distribution and secretion of radiolabeled temoporfin in a murine tumor model, Photochem. Photobiol. 63 (1996) 885-891.
26. [26] D.A. Bellnier, T.J. Dougherty, The time course of cutaneous porphyrin photosensitization in the murine ear, Photochem. Photobiol. 49 (1989) 369-372.
27. [27] V.H. Fingar, Vascular effects of photodynamic therapy, J. Clin. Laser Med. Surg. 14 (1996) 323-328.
28. [28] V.H. Fingar, T.J. Wieman, P.S. Karavolos, K.W. Doak, R. Ouellet, J.E. van Lier, The effects of photodynamic therapy using differently substituted zinc phthalocyanines on vessel constriction, vessel leakage and tumor response, Photochem. Photobiol. 58 (1993) 251-258.
29. [29] M. Korbelik, G. Krosl, J. Krosl, G.J. Dougherty, The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy, Cancer Res. 56 (1996) 5647-5652.
30. [30] S. Evans, W. Matthews, R. Perry, D. Fraker, J. Norton, H.I. Pass, Effects of photodynamic therapy on tumor necrosis factor production by murine macrophages, J. Natl. Cancer Inst. 82 (1990) 34-39.
31. [31] U.O. Nseyo, R.K. Whalen, M.R. Duncan, B. Berman, S.L. Lundhal, Urinary cytokines following photodynamic therapy for bladder cancer, Urology 36 (1990) 167-171.
32. [32] S.O. Gollnick, X. Liu, B. Owczarczak, D.A. Musser, B.W. Henderson, Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo, Cancer Res. 57 (1997) 3904-3909.
33. [33] H.W. Herr, D.M. Schwalb, Z.F. Zhang, P.C. Sogani, W.R. Fair, W.F. Whitmore Jr., H.F. Oettgen, Intravesical Bacillus Calmette-Guérin therapy prevents tumor progression and deaths from superficial bladder cancer: ten-year follow-up of a prospective randomized trial, J. Clin. Oncol. 13 (1995) 1404-1408.